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The proviral clones 61E and 61C represent two closely related variants of feline leukemia virus (FeLV) that exhibit
significant differences in their biological and pathogenic properties. The major pathogenic determinant has been mapped to
the extracellular envelope glycoprotein (Env-SU), but the mechanism by which envelope differences influence pathogenesis
is not well understood. Moreover, it is unclear whether these viruses infect the same target cells and/or enter cells using the
same receptor. In the present study, we exploited a recently developed single cycle infection assay to examine the host range
and interference properties of 61E and 61C FeLVs and found that these two FeLV variants differ significantly in their host
ranges and receptor usages. FeLV-61C was found to be an ecotropic virus; the entry of viruses bearing a 61C envelope
protein (Env-SU) into cell lines was limited to feline T-cells and feline fibroblasts. In contrast, the host range of 61E includes,
in addition to all feline cells examined, some canine, murine, and human cell lines. Feline fibroblast and feline T-cells that
expressed 61E envelope were resistant to infection with a virus bearing a 61E Env-SU, whereas these same cells were
susceptible to infection by an otherwise similar virus pseudotyped with the 61C Env-SU. This pattern of interference was
observed in cells expressing 61E envelope alone, in the absence of other FeLV gene products, demonstrating that
interference was mediated specifically by Env-SU. Fibroblast cells chronically infected with a 61C virus were partially
resistant to infection with a virus having a 61C Env-SU, but were not resistant to infection by a virus having a 61E Env-SU.
On the basis of the current understanding of virus–receptor interactions, the lack of interference between 61E and 61C under
conditions where there is significant homologous interference, combined with the differences in their host cell range, leads
us to conclude that 61E and 61C use two distinct primary cellular receptors for entry. © 1998 Academic Press
INTRODUCTION
Feline leukemia virus (FeLV) infection in cats can lead
to several disease outcomes that are largely dependent
on the genetic characteristics of the infecting virus vari-
ant (Rohn and Overbaugh, 1997). This has been illus-
trated in experimental infections of cats with molecularly
cloned variants. For example, the FeLV-C-Sarma molec-
ular clone has been shown to reproducibly cause aplas-
tic anemia in cats (Riedel et al., 1986). Similarly, the
FeLV-61C-derived chimeric cloned virus EECC causes
immunodeficiency disease in cats, whereas a closely
related virus, FeLV-61E, is relatively avirulent (Overbaugh
et al., 1988). For both the anemia-inducing FeLV-C-Sarma
virus and the immunodeficiency-inducing EECC variant,
the gene coding for the extracellular surface glycoprotein
(Env-SU) has been shown to encode the primary deter-
minant of their unique pathogenicity (Donahue et al.,
1991; Quackenbush et al., 1990; Riedel et al., 1988).
The mechanism by which FeLV Env-SU affects disease
outcome is not known. Because the surface envelope
protein specifically interacts with a cellular receptor to
initiate viral entry, it is possible that envelope–receptor
interactions could signal downstream events that con-
tribute to cell dysfunction. The murine retrovirus spleen
focus-forming virus (SFFV) provides a classic example of
how envelope-initiated receptor signaling may lead to a
specific disease outcome. Binding of SFFV envelope
protein to the erythropoietin receptor mimics the normal
ligand signal, leading to specific proliferation of erythroid
cells, which express this receptor (reviewed in Ben-
David and Bernstein, 1991). Of particular relevance to
cytopathic FeLV-61C infection, recent studies of cyto-
pathic avian leukosis viruses illustrate a direct role for
envelope–receptor interactions in virus-associated cell
killing. In this case, the receptor for cytopathic avian
retrovirus variants is CAR1, a protein that signals apop-
tosis and cell death when bound to the viral envelope
protein (Brojatsch et al., 1996).
Specific receptor interactions also determine host cell
specificity, and in this manner may define the target
cell(s) that will be adversely affected by virus infection.
For example, HIV recognizes the CD4 molecule on the
helper subset of T lymphocytes and consequent immu-
nodeficiency results primarily from destruction of this cell
population. The receptor-binding properties of FeLV have
largely been inferred by superinfection interference stud-
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ies, which were the basis for defining three major sub-
groups of FeLV (A, B, and C; Sarma and Log, 1971). In this
regard, the contrasting virulence of the subgroup C,
anemia-inducing FeLV-C-Sarma and the mildly patho-
genic subgroup A FeLV-61E may be explained, in part, by
differences in receptor specificity (Kristal et al., 1993).
The subgroup of the immunodeficiency-inducing 61C
variant has not been clearly defined. This virus replicates
with high efficiency in feline T-cell lines compared to
other FeLV clones (Donahue et al., 1991; Rohn et al.,
submitted for publication), and viruses encoding the 61C
envelope protein have been shown to have a limited
ability to establish superinfection interference in T-cells
(Donahue et al., 1991; Kristal et al., 1993; Reinhart et al.,
1993), suggesting that perhaps a unique envelope–re-
ceptor interaction may be associated with infection by
this variant. Interference studies of 61C and 61E that
relied on virus replication as a measure of infection have
been difficult to interpret and have yielded somewhat
contradictory information compared to envelope-binding
studies (Kristal et al., 1993; Reinhart et al., 1993).
Interference studies have historically provided an im-
portant tool for analyzing whether two viruses share a
common receptor (reviewed in Weiss, 1984). Because the
interference and overlapping receptor specificities of the
avirulent 61E and highly virulent 61C variants are unre-
solved, we developed a single-cycle infection assay de-
signed to measure viral entry and receptor interactions.
Using this approach, we showed that 61E and EECC
have clearly distinct host cell ranges. Moreover, the 61E
and 61C envelope proteins do not exhibit any reciprocal
interference. Taken together, these data are most con-
sistent with a model in which the 61E and 61C viruses
recognize distinct cellular receptors for viral entry.
RESULTS
Superinfection interference studies in feline
fibroblast cells
Feline fibroblast cells that were chronically infected
with 61E (61E-AH927) or EECC (EECC-AH927) were used
as targets for superinfection interference studies. Prior to
interference studies, processing and surface expression
of the viral envelope protein were examined. Env-SU was
immunoprecipitated from radiolabeled lysates of EECC-
AH927 and 61E-AH927 cells using a FeLV-SU-specific
monoclonal antibody, C11D8 (Grant et al., 1983). The
unprocessed envelope (gp85) and the processed Env-SU
(gp70) proteins were readily detected by SDS–PAGE
analysis of immunoprecipitates (Burns et al., 1995 and
data not shown). To determine what fraction of the cells
were infected, cell surface expression of FeLV envelope
was examined by flow cytometry analysis using C11D8
antibody. There was a unimodal distribution of cells that
was shifted to the right relative to uninfected cells, sug-
gesting that essentially all the cells expressed Env-SU.
The mean fluorescence intensity was higher for EECC-
infected cells than for 61E-infected cells, suggesting
there was a higher level of Env-SU expression in the
EECC-AH927 than the 61E-AH927 cell line (Fig. 1A). This
observation was consistent with data from immunopre-
cipitations using the C11D8 antibody (Burns et al., 1995)
and with results obtained by Southern blot analysis,
which demonstrated a higher copy number of EECC than
61E in the respective cell lines (data not shown).
The cell lines that were examined in Fig. 1A were used
as targets for infection by 61E-DC/LAPSN and EECC-
DC/LAPSN. In all experiments, A-MuLV/LAPSN or A-
MuLV/LXSN was used as a positive control and was
shown to enter both FeLV-infected and uninfected AH927
fibroblasts with similar efficiencies (within 2-fold; Fig.
1B). In each experiment, target cells that were mock
infected with media and subjected to G418 selection
resulted in no background colonies. Cells infected with
61E (61E-AH927 cells) were resistant to challenge by
homologous virus. There were no cells that expressed
the viral vector RNA, as judged by selection for G418
resistance, when 61E-AH927 cells were challenged with
5 3 103 cfu of 61E-DC/LAPSN (m.o.i. 0.0125). Therefore,
infection by 61E-DC/LAPSN was reduced by at least
5000-fold in 61E-AH927 cells compared to naive AH927
cells. To determine the limits of this resistance, up to 5 3
105 cfu 61E-DC/LAPSN virus was used to infect 61E-
AH927 cells. At the higher m.o.i.s (0.125 and 1.25) used in
these experiments, 3 and 30 G418 resistant colonies per
infection were detected, respectively. This level of infec-
tion represented an approximately 4 log unit reduction in
61E-DC/LAPSN infectivity in 61E-AH927 cells compared
to infection of AH927 cells.
In contrast to the results with 61E virus challenge,
there was no significant interference when 61E-AH927
cells were infected with EECC-DC/LAPSN. EECC-DC/
LAPSN infection of 61E-AH927 cells resulted in an aver-
age of 4500 cfu, which was similar to the number of
colony forming units (6100) observed when naive AH927
cells were infected in parallel with an equal amount of
EECC-DC/LAPSN (Fig. 1B). These experiments demon-
strate that in a cell line where there was essentially
complete resistant to 61E virus challenge, there was no
resistance to infection by an otherwise similar virus
encoding a 61C Env-SU.
Consistent with previous results (Donahue et al., 1991;
Kristal et al., 1993; Reinhart et al., 1993), our data suggest
that the 61C Env-SU is impaired in its ability to establish
superinfection interference. However, in the EECC-
AH927 cells, which express high levels of surface
Env-SU (Fig. 1A), we consistently detected partial inter-
ference to homologous virus challenge. In repeated ex-
periments with multiple virus stocks, we observed an
average 11-fold reduction (with a range of 6- to 60-fold
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among experiments) with EECC-DC/LAPSN virus infec-
tion of EECC-AH927 cell line compared with infection of
naive AH927 cells (Fig. 1B). 61E-DC/LAPSN entry into
the EECC-AH927 cell line was reduced, on average,
3-fold compared to entry into AH927. Similarly, there was
a very modest decrease (about 2-fold) in A-MuLV/LAPSN
infection of EECC-AH927 cells relative to AH927 which
may suggest that these 2- to 3-fold differences are due to
FIG. 1. Superinfection interference studies in AH927 feline fibroblast cells using viruses from FeLV packaging cells. (A) Flow cytometric analysis
of Env-SU expression in 61E- and EECC-infected AH927 cells using the C11D8 monoclonal antibody to Env-SU. The legend to the right describes the
cell lines analyzed. The relative cell number is plotted against the mean fluorescence intensity. (B) Superinfection interference assay using A-MuLV,
61E-DC/LAPSN, or EECC-DC/LAPSN. The viruses used for infection are indicated below the column and in all cases infection was at an m.o.i. of
0.0125. The cell lines are designated with different patterns of shading as shown in the legend to the right. The height of the column represents the
log of the colonies per infection. The data in this figure represent an average of four independent experiments and error bars represent the standard
deviation between experiments. Viruses from two independent 61E-DC/LAPSN cell lines and two independent EECC-DC/LAPSN cell lines were used
in some experiments to verify results. A-MuLV packaging either LAPSN or LXSN was used, and resulting colony numbers were averaged and
indicated as A-MuLV/LAPSN for simplicity. In each experiment target cells that were not challenged with virus were subjected to G418 selection, and
in each case there were no background colonies (data not shown).
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nonspecific events, and/or represent the limits of error in
these experiments.
To validate our studies using the FeLV packaging sys-
tem, we performed interference assays using replication
competent virus carrying the LXSN vector (Fig. 2). A 61E
virus that copackaged LXSN (61E/LXSN) did not infect
61E-AH927 cells, but did infect EECC-AH927 cells as
efficiently as it infected naive AH927 cells. As was ob-
served with EECC-DC, there was partial interference
against replication competent EECC/LXSN in EECC-
AH927 cells, in this case, infection was reduced by
23-fold in EECC-AH927 versus AH927 cells. There was
no interference to 61E/LXSN infection in EECC-AH927
cells. These studies demonstrate that interference
against EECC/LXSN and 61E/LXSN was similar to that of
EECC-DC/LAPSN and 61E-DC/LAPSN, respectively:
cells expressing 61E Env-SU were resistant to homolo-
gous virus infection but not to infection with a virus
having a 61C Env-SU, and there was partial interference
in cells expressing 61C Env-SU against homologous vi-
rus infection but not 61E infection.
Superinfection interference studies in T-cells
To avoid complications resulting from the cytopathic
effects of replication competent EECC in feline T-cells,
we examined the ability of envelope expression (either
61C or 61E) alone to interfere with 61E-DC/LAPSN or
EECCDC/LAPSN infection in these cells. Pools of G418
resistant cells encoding the LCSN or LESN vector
(LCSN-3201 or LESN-3201 cells, see Materials and
Methods) were examined for cell surface Env-SU expres-
sion by flow cytometry using a monoclonal antibody,
C11D8, that recognizes the Env-SU protein of FeLVs
(Burns et al., 1995; Grant et al., 1983). Cell surface ex-
pression above the background of the parental 3201 cell
line could readily be detected in both LESN-3201 and
LCSN-3201 cells (Fig. 3A). These cells were challenged
with 61E-DC/LAPSN or EECC-DC/LAPSN virus, and in-
fected cells were identified by FACS analysis for alkaline
phosphatase expression. The expression of 61C Env-SU
in LCSN-3201 cells did not interfere with the entry of
either EECC-DC/LAPSN or 61E-DC/LAPSN viruses (Fig.
3B). In LESN-3201 cells, there was an approximately
60-fold decrease in 61E-DC/LAPSN entry compared to
infection of naive cells. A 60-fold reduction probably
represents a conservative estimate because the number
of alkaline phosphatase-positive cells among LESN-3201
cells challenged with 61E-DC/LAPSN virus was indistin-
guishable from background (staining of uninfected cells;
Fig. 3B). There was no interference to EECC-DC/LAPSN
FIG. 2. Superinfection interference studies in AH927 feline fibroblasts cells using replication competent virus. Experimental procedure and layout
are as described in the legend to Fig. 2, except that three separate experiments were performed with a single virus stock of each FeLV.
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FIG. 3. Interference studies in feline 3201 T-cells. (A) Flow cytometric analysis of Env-SU expression in LCSN-3201, LESN-3201, and LXSN-3201 using
C11D8 monoclonal antibody. Relative cell number is plotted against mean fluorescence intensity and the designation for each cell line is indicated
to the right. (B) Interference assay with 3201 cells expressing FeLV Env-SU. LCSN-3201, LESN-3201, and LXSN-3201 cells were infected with either
EECC-DC/LAPSN or 61E-DC/LAPSN. Alkaline phosphatase expression was used as a marker for infection and was detected by flow cytometry using
an anti-alkaline phosphatase monoclonal antibody as described under Materials and Methods. The number of positive cells was calculated by
determining the percentage of events in the gated region that fluoresced above background levels.
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infection in LESN-3201 cells when compared with infec-
tion of naive cells (Fig. 3B). Thus, expression of 61E
Env-SU in 3201 feline T-cells, in the absence of other
gene products, was sufficient to establish superinfection
interference against homologous, but not heterologous,
viral challenge.
Host range studies
We exploited our single-cycle infection assay to eval-
uate the host range of 61E and 61C viruses. Because this
assay does not require production of virus in target cells
and subsequent virus spread, we could evaluate viral
entry events related to receptor interactions. As a control
for these experiments, a subgroup B FeLV, EEZZ/LAPSN,
was used because it exhibits a broad host range that
includes both feline and nonfeline cells (Boomer et al.,
1997, 1994). On the basis of such infection studies with
EECC-DC/LAPSN and 61E-DC/LAPSN, we demon-
strated that the host ranges of 61E and 61C are clearly
distinct (Table 1).
EECC-DC/LAPSN efficiently infected feline 3201 T-
cells (Table 1). EECC-DC/LAPSN was also infectious for
feline fibroblast AH927 cells, although the titers were 6 3
103 CFU per milliliter, which was approximately 100-fold
lower than the titer of the same virus stock in T-cells.
EECC-DC/LAPSN was unable to gain entry into other
cell lines tested, which included D17, MMK, Vero, NIH
3T3, MDTF, 293, and Hos cells using as much as 0.5 ml
of virus (Table 1).
61E-DC/LAPSN was highly infectious for both feline
fibroblasts and feline T cells (Table 1). In addition, the
host range of 61E-DC/LAPSN included a number of non-
feline cell lines. 61E-DC/LAPSN was able to infect D17
canine osteosarcoma cells at relatively high levels (1 3
103 ffu per milliliter). There was a very low, but reproduc-
ible level of infection of 61E-DC/LAPSN in Vero, African
green monkey kidney cells; we detected occasional al-
kaline phosphatase-positive cells in multiple infections
with 61E-DC/LAPSN (average of 8 ffu per milliliter), com-
pared to the EEZZ/LAPSN control, which had titers of 6 3
103 ffu per milliliter in Vero cells. Surprisingly, 61E-DC/
LAPSN was infectious in 293 human embryonic kidney
cells at a level comparable to subgroup B EEZZ/LAPSN
(7 3 104 ffu per milliliter). The efficiency of infection of
61E-DC/LAPSN into 293 cells was about 15-fold lower
than in AH927 cells. Hos human osteosarcoma cells
were also susceptible to 61E-DC/LAPSN, although at
relatively low levels (1 3 102 ffu per milliliter). In addition,
61E-DC/LAPSN infected MMK feral mouse kidney cells,
although the titer was reduced by almost 4 logs com-
pared to titers of the same virus stock in AH927 cells.
The subgroup B virus EEZZ also infected the murine
MMK cell line. None of the FeLVs tested, including 61E-
DC/LAPSN or EEZZ/LAPSN, were able to infect either
NIH 3T3, a murine fibroblast cell line, or MDTF, Mus
dunni tail fibroblasts.
DISCUSSION
Host range and interference studies have classically
been used to determine whether viruses recognize the
same or different receptor molecules for entry (Weiss,
1984). The patterns of receptor recognition by 61E and
61C FeLV variants are of particular interest because
these viruses share approximately 98% amino acid iden-
tity in their envelope proteins, yet they exhibit very dis-
tinct pathogenicities as a result of these differences in
envelope (Donahue et al., 1991; Overbaugh et al., 1988;
Quackenbush et al., 1990). On the basis of our host range
and interference studies, we conclude that these two
closely related FeLV variants recognize distinct recep-
TABLE 1
Host Range Studies Using FeLV Particles Carrying the LAPSN Vector a
Alkaline phosphatase ffu per milliliter
61E-DC/LAPSN EECC-DC/LAPSN EEZZ/LAPSN
AH927 feline fibroblastb 1 3 106 6 3 103 5 3 106
3201 feline T cellb $5 3 105 7 3 105 ND
NIH 3T3 murine fibroblast 0 0 0
MMK feral murine kidney 2 3 102 0 5 3 103
MDTF Mus dunni tail fibroblast 0 0 0
D17 canine osteosarcoma 1 3 103 0 1 3 105
Vero African green monkey kidney 8 0 6 3 103
293 human embryonic kidney 7 3 104 0 7 3 104
Hos human osteosarcoma 1 3 102 0 1 3 104
a Cells were infected with the viruses indicated above the columns and then stained for alkaline phosphatase (AP) expression at 2 days
postinfection. Values of zero indicate that no AP-positive cells were detected using as much as 500 ml of virus supernatant in multiple infections.
b Values reported for AH927 and 3201 cells are cfu per milliliter (G418R titers) rather than ffu per milliliter. In general, the AP titers were 2- to 5-fold
lower than the G418R titers, except that the AP titer for EECC-DC/LAPSN infection of AH927 was 500-fold lower than the G418R titer.
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tors. Thus, these data suggest that the immunodeficien-
cy-inducing FeLV-61C variant may define a distinct sub-
group of FeLV.
Recent interference studies of MuLV have highlighted
the value of assays that measure viral entry, rather than
assays that rely on virus spread, for defining patterns of
receptor interactions between viruses (Miller and Wolga-
mot, 1997). The different viruses used in the studies
described here were assembled with identical Gag and
Pol proteins, as well as packaged vector RNA; thus,
differences in the infectivity of viruses that contained
different envelope proteins can be attributed specifically
to envelope interactions. This approach circumvented
any differences that might occur in later stages of virus
replication and allowed us to directly examine a single
cycle of FeLV infection in the absence of virus spread.
The data from earlier studies that used other methods
for measuring the infection properties of the 61C (EECC)
variant were generally difficult to interpret. For example,
in experiments using either a nonreciprocal VSV interfer-
ence assay or a nonquantitative ELISA assay for virus
spread, the authors were unable to conclude as to
whether 61E and 61C use a common or distinct receptor
(Kristal et al., 1993). These experiments may have been
complicated, in part, by the fact that only a small number
of events were scored and there was relatively modest
interference (typically 1–2 logs) between homologous
viruses, making it difficult to interpret the significance of
small differences in heterologous virus challenge exper-
iments. There were similar limitations in interference
studies that relied on PCR analyses of viral RNA after
virus spread in culture (Reinhart et al., 1993). Between
these various studies, there were some assay-depen-
dent differences in the ability of EECC to infect cells
expressing 61E that further confounded interpretation
(Reinhart et al., 1993). Overall, the data were most con-
sistent with a model in which the 61E and EECC viruses
used different receptors for viral entry. In contrast, addi-
tional studies showing that phosphatidylinositol-linked
61E and 61C envelope proteins expressed in Chinese
hamster ovary cells competitively bound to a 70-kDa
protein suggested that the 61E and EECC viruses may
use a common receptor molecule (Reinhart et al., 1993).
However, subsequent studies showing that the gene
coding for the purified 70-kDa protein, which was iden-
tified as alkaline phosphatase (Ghosh and Mullins, 1995),
does not function as either a 61E or 61C receptor, now
make interpretation of the binding studies problematic.
FeLV-61E has typically been considered a prototype
subgroup A FeLV (Donahue et al., 1988; Kristal et al.,
1993), and earlier studies using uncloned FeLV-A iso-
lates reported that replication of FeLV-A was generally
restricted to feline cells (Jarrett et al., 1973). Subsequent
studies showed that select FeLV-A isolates could infect
canine and/or human cells, but generally with low effi-
ciency (Sarma et al., 1975). Interestingly, we found that
the 61E virus can infect certain human cell lines, and, in
the case of human 293 embryonic kidney cells, there
was a high level of infection. Our studies also demon-
strated that FeLV-61E can infect a canine cell line (D17),
and a murine kidney cell line (MMK) derived from a feral
Asian mouse, albeit with reduced efficiency relative to
infection of feline cells. This is the first example of FeLV
infection in murine cells, and both FeLV-61E and the
subgroup B virus FeLV-EEZZ infected MMK cells. Neither
virus infected other murine cells that we examined,
which may suggest that there are other blocks to infec-
tion specific to these murine cells. Interestingly, MMK
cells are also susceptible to infection by a related retro-
virus, gibbon ape leukemia virus (GALV), and MMK cells
have been shown to encode a form of the GALV receptor
Pit1 that is divergent from other murine alleles (Wilson et
al., 1994). Thus, EEZZ, which can utilize human Pit1 as a
receptor (Boomer et al., 1997), may also enter MMK cells
using the same MMK variant Pit1 protein. By analogy, the
MMK murine kidney cells may encode a variant of the
murine allelle of the 61E receptor that can be recognized
by 61E Env-SU. In this regard, there is precedent for the
fact that a single mutation can alter envelope–receptor
recognition for GALV; studies of the human Pit2 receptor
have demonstrated that the introduction of a single
amino acid change in this protein is sufficient to allow
Pit2 to function as a GALV receptor (Eiden et al., 1996).
The observation that 61E can infect a fairly wide range
of heterologous cells may reflect a unique property of
this molecular clone that distinguishes it from some of
the original FeLV-A isolates that were restricted to repli-
cation in feline cells (Jarrett et al., 1973). There is some
indirect support for a model invoking differences in the
receptor alleles recognized by variants within a sub-
group: recent studies from our laboratory have shown
that some FeLV-B variants differ in their receptor recog-
nition properties and in their abilities to interact with
species-specific receptors (Boomer et al., 1997). Alterna-
tively, the experiments presented here, which measure
viral entry and early events in infection, may simply
provide a more accurate indication of the ability of
FeLV-A to interact with receptor proteins expressed in
nonfeline cells. By comparison, the inability of some
FeLV-As to infect heterologous cells may have been the
result of restrictions to replication at later stages in the
viral replication cycle. In any case, the ability of 61E to
infect heterologous cells suggests that 61E envelope can
recognize a receptor homologue from several nonfeline
species.
The host range of EECC was clearly distinct from that
of 61E. EECC did not infect any nonfeline cell types, even
those such as human 293 cells, which were readily
infectable by 61E. There are at least two models to
explain these data: (1) there is a common feline receptor
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for 61C and 61E, and there are sequence differences in
the human homologue that abolish recognition by 61C,
but not 61E; or (2) 61C and 61E Env-SU recognize distinct
receptors, and the host range differences between the
two viruses reflect the patterns of expression of each
specific viral receptor. The former model does not ade-
quately explain the fact that there is differential infectivity
between the two viruses in feline cells. Thus, the host
range data are most consistent with a model involving
two receptors.
Fibroblast cells that were chronically infected with 61E
were resistant to infection by homologous virus. In con-
trast, we did not detect any interference in these cells
against an otherwise similar virus with a 61C envelope
protein. Conversely, fibroblast cells infected with EECC
were partially resistant to homologous infection, but
showed no interference to 61E infection. T-cells express-
ing 61C envelope protein did not block infection with a
virus bearing the 61C Env-SU. However, complete homol-
ogous interference was observed in T-cells expressing
only the 61E Env-SU, demonstrating that the interference
is mediated specifically by the envelope protein. These
61E envelope expressing T-cells were not resistant to
infection by virus encoding 61C envelope Env-SU, dem-
onstrating that the pattern of nonreciprocal interference
observed in fibroblast cells is not cell specific.
The lack of reciprocal interference between the 61E
and 61C envelope proteins strongly suggests that these
proteins recognize different receptor molecules to medi-
ate viral entry. In this regard, it is important to emphasize
that our studies show that 61C can enter 61E-infected
cells that are, in parallel experiments, completely resis-
tant to homologous virus challenge. These data are not
consistent with a model based on differences in enve-
lope–receptor affinity for a single receptor, because the
complete resistance to 61E infection in cells expressing
61E Env-SU strongly implies that the 61E receptor is no
longer available for attachment on the surface of these
cells. If 61C had a lower affinity than 61E for a common
receptor, the EECC virus should not superinfect cells
expressing 61E envelope that are resistant to 61E infec-
tion. Moreover, if 61C Env-SU had a higher affinity than
61E for a common receptor, it is difficult to explain why
cells infected with 61C are not highly resistant to both
61C and 61E virus infections. A high affinity envelope
receptor interaction would be predicted to lead to enve-
lope mediated receptor downregulation and consequent
resistance to reinfection. Thus, taken together, the data
from both interference and host range studies using a
single cycle replication assay strongly suggest that 61E
and 61C envelopes recognize different receptor mole-
cules.
FeLV-EECC and other chimeras that encode a 61C
Env-SU are cytopathic and highly T-cell-tropic viruses
(Donahue et al., 1991). T-cell killing has been associated
with an inability of 61C Env-SU to establish superinfec-
tion interference (Donahue et al., 1991; Kristal et al., 1993;
Reinhart et al., 1993). Although a specific mechanism for
cell killing following superinfection has not been defined,
it is likely that the high level of virus replication associ-
ated with reinfection could contribute to the cytopathic
effects of such viruses. In the case of FeLV 61C variants,
it appears that the envelope may recognize a unique
receptor that is not sufficiently modulated by envelope
binding to limit subsequent infection by homologous
virus.
The recognition of different receptor molecules by 61E
and 61C envelope proteins may contribute to the distinct
virulence properties of each virus in the host. At the very
least, receptor expression will partially govern the cells
and tissues that are infected by each virus. Interactions
between the 61C Env-SU and a specific cellular receptor
may also have direct consequences for cytopathicity, as
has been observed for cytopathic avian retrovirus vari-
ants (Brojatsch et al., 1996). Current efforts are directed
at isolating molecules that function as cellular receptors
for 61E and 61C so that these models of pathogenesis
may be explored.
MATERIALS AND METHODS
Growth media for cell culture
Feline 3201 T cells were cultured in media composed
of an equal mixture of L15 and RPMI, supplemented with
15% fetal bovine serum. Feline AH927 fibroblast and 293
human embryonic kidney cells (Graham et al., 1977)
were cultured in minimum essential medium (MEM) and
10% fetal bovine serum. Vero, African green monkey
kidney cells (ATCC No. CCL-81), were cultured in MEM
supplemented with 5% fetal bovine serum. The following
cells were cultured in Dulbecco’s modified Eagle me-
dium (DMEM) with 10% fetal bovine serum: D17, canine
osteosarcoma cells (Riggs et al., 1974); NIH 3T3 murine
fibroblast cells and their derivatives expressing MuLV
proteins, PA317 and PE501 cells (Miller and Rosman,
1989); MDTF, Mus dunni tail murine fibroblast cells
(Lander and Chattopadhyay, 1984); MMK, M. musculus
molossinus kidney cells (Wilson et al., 1994); Hos, human
osteosarcoma cells (McAllister et al., 1971). In each case,
the medium was supplemented with 100 units penicillin
per milliliter, 100 mg streptomycin per milliliter 0.25 mg
amphotericin fungicide per milliliter and 2 mM L-glu-
tamine. All reagents for tissue culture were from Gibco-
BRL (Grand Island, NY).
Origin of chronically infected cell lines
AH927 cells chronically infected with 61E were gener-
ated by transfecting a plasmid encoding the 61E provirus
into naive cells and allowing the virus to spread in
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culture (61E-AH927 cells, previously described as
JOAHE4 cells; Rohn et al., 1994). Since EECC replicates
with low efficiency in AH927 cells, the provirus was
transfected into 3201 cells, and high titer viral superna-
tant from these cells was used to infect AH927 cells (in
the presence of polybrene) to generate an AH927 cell
line chronically infected with EECC (Rohn et al., submit-
ted for publication). The MuLV-based vector LXSN, which
encodes the neomycin resistance gene, was introduced
into AH927 cells chronically infected with FeLV by infec-
tion with amphotropic MuLV particles that packaged
LXSN (A-MuLV/LXSN), which were generated as previ-
ously described (Miller and Rosman, 1989). Viruses de-
rived from 61E-AH927 and EECC-AH927 cells expressing
LXSN are referred to as 61E/LXSN and EECC/LXSN,
respectively. A subgroup B FeLV (EEZZ; Boomer et al.,
1994) carrying the vector LAPSN, which is a derivative of
LXSN that has been modified to express alkaline phos-
phatase (Miller et al., 1994), has been described previ-
ously (EEZZ/LAPSN; Boomer et al., 1997).
Plasmid constructions
Sequences coding for surface (Env-SU, gp70) and
transmembrane (Env-TM, p15E) envelope proteins from
61E and from 61C were introduced into the multiple
cloning site of pLXSN. For this purpose, a plasmid en-
coding 61E provirus was digested with RsrII, which rec-
ognizes a site near the end of the sequence coding for
the Env-TM (nucleotide 7898), and ligated to a linker that
reconstructed the last 12 bases of the envelope se-
quence and included a 39 BamHI site for cloning. This
linker was made by the hybridization of two oligonucle-
otides: (1) 59 GACCGACCATGATTG and (2) 59 GATC-
CAATCATGGTCG (Fig. 4). Following ligation to the linker,
the DNA was then digested with BamHI, which recog-
nizes a restriction site in the pol gene just upstream of
the envelope coding sequences, as well as the new site
in the linker. The resulting 2.7-kb BamHI envelope frag-
ment was purified following electrophoresis and ligated
into the BamHI site of pLXSN, resulting in the construct
LESN. A construct was made in the same manner using
the envelope sequences from a plasmid encoding 61C
and is referred to as LCSN (Fig. 4).
A packaging-deficient 61E provirus encoding a 107-
base pair deletion in the sequence required for viral RNA
packaging (C) was described previously (61E-DC; Burns
et al., 1996). For the present study, a similar packaging-
deficient EECC provirus (EECC-DC) was constructed.
EECC-DC is a chimeric provirus containing sequences
encoding the 59LTR, gag, and pol from 61E-DC (Burns et
al., 1996) and sequences encoding Env-SU, Env-TM, and
39LTR from 61C (Fig. 4). This construct was generated by
ligating a gel-purified '4 kb SalI/BglII fragment of p59-
61E-DC (Burns et al., 1996), to an '8-kb gel-purified,
similarly digested fragment from pEECC. The EECC-DC
construct was verified by restriction enzyme digestion
and subsequent analysis.
Packaging cell lines
The construction of a FeLV packaging cell line ex-
pressing 61E-DC in canine D17 cells has been previ-
ously described (D17-61E-DC; Burns et al., 1996). LAPSN
was introduced into D17-61E-DC cells by infection with
virus from a PG13 packaging cell line (Miller et al., 1991)
that expressed the LAPSN vector (PG13/LAPSN). Virus
expressed from the resulting D17-61E-DC cell line is
referred to as 61E-DC/LAPSN. To prepare the equivalent
cell line expressing EECC, EECC-DC was cotransfected
with calcium phosphate (Stratagene) into D17 cells with
a plasmid encoding CMV-hph (Aronoff and Linial, 1991)
and selected in 155 units hygromycin B (Calibiochem,
San Diego, CA) per milliliter. Hygromycin-resistant colo-
nies were isolated and screened for high levels of re-
verse transcriptase activity as described previously
(Burns et al., 1996; Goff et al., 1981). A cell line coex-
pressing EECC-DC and LAPSN was made by the intro-
duction of LAPSN into D17-EECC-DC by infection with
PG13/LAPSN. The resulting virus expressed is referred
to as EECC-DC/LAPSN.
Flow cytometry analysis
Flow cytometry was performed on a Becton–Dickinson
FACS Star Plus. To stain cells in preparation for flow
cytometry, fibroblasts were removed from flasks using
versene, 5 mM EDTA in PBS. The remaining steps were
the same for both T-cells and fibroblasts: 2 3 105 cells
were washed in PBS, followed by wash buffer (WB),
which consisted of Hanks balanced salt solution, 2%
fetal bovine serum, and 0.08% sodium azide. The cells
were incubated in 50 ml WB with a dilution of the primary
antibody at 37°C for 25 min. C11D8 was the primary
antibody used for detection of Env-SU (Grant et al., 1983);
this monoclonal has been shown to recognize both 61E
Env-SU and 61C Env-SU (Burns et al., 1995; Grant et al.,
1983; Kristal et al., 1993; Poss et al., 1989, 1990). A
anti-human placental alkaline phosphatase mouse IgG2
(Sigma, St. Louis, MO) was the primary antibody used for
detection of alkaline phosphatase. Following incubation
with the primary antibody, the cells were washed three
times in WB and incubated in 50 ml WB with a dilution of
the secondary antibody on ice in the dark for 15 min. The
following secondary antibodies were used: goat anti-
mouse IgG2b FITC (Southern Biotechnologies, Birming-
ham, AL) for C11D8 and anti-mouse IgG2a FITC (Boeh-
ringer–Mannhein) for the antibody that recognizes
alkaline phosphatase. Following incubation with the sec-
ondary antibody, cells were washed three times, resus-
pended in 0.5 ml WB, and added to 0.5 ml of 2% para-
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FIG. 4. Schematic representation of proviral DNAs and retroviral vectors containing 61E and 61C sequences. (A) The regulatory and coding
sequences of the retroviral genome or the vector are labeled below each construct. Each parental viral genome is designated by a particular shading
as indicated at the top right; portions of each genome that were derived from these parental clones are also indicated by use of shading. Exchanges
of proviral segments of DNA were made at the restriction sites indicated (see Material and Methods). The XhoI site indicates the border between
61C and the 61E sequences in EECC-DC. (B) Schematic representation of virus particles. The vector and/or viral genomic RNA that is packaged into
the virion is labeled. The Env-SU protein is shown as small circles and shading indicates the origin of the protein, as shown in the upper corner of
A. As indicated, A-MuLV/LCSN and A-MuLV/LESN presumably contain both MuLV and FeLV Env-SU proteins on the virion.
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formaldehyde in PBS. Staining for the sorting of viable
cells was performed in the same manner except that all
volumes and the number of cells were increased fivefold,
sodium azide was omitted from the WB, and cells were
not fixed with paraformaldehyde.
Feline cell lines expressing FeLV envelope
Plasmids encoding LESN, LCSN, and LXSN were
transfected into MuLV packaging cell lines (Miller and
Rosman, 1989) and the resulting MuLV carrying these
vectors was used to infect feline 3201 T-cells in the
presence of 4 mg polybrene per milliliter. After selection
for 4 weeks in 2 mg G418 (Geneticin; approximately 60%
active drug, Gibco-BRL) per milliliter, cells that survived
were further enriched by flow cytometry using the C11D8
antibody, as described above. Cells expressing high lev-
els of Env-SU were collected for use in superinfection
studies. The resulting cell lines expressing LESN, LCSN,
and LXSN are referred to as LESN-3201, LCSN-3201, and
LXSN-3201, respectively.
Fibroblast interference studies
For interference studies in fibroblasts, AH927 cells
(uninfected and infected) were seeded onto 6-cm dishes
at 2 3 105 cells per dish. The following day, plates were
infected with EECC-DC/LAPSN, 61E-DC/LAPSN, or am-
photropic MuLV that packaged LAPSN or LXSN (A-MuLV/
LAPSN or A-MuLV/LXSN) in 4 ml fresh media containing
4 mg polybrene per milliliter. In parallel, target cells were
mock infected with media containing polybrene. On Day
3, the plates were trypsinized and split 1:10 into two to
four 10-cm plates in media with 0.7 mg G418 (Geneticin;
approximately 60% active drug, Gibco-BRL) per milliliter.
The G418 media was replaced every 2 to 3 days until Day
11 or 12 when cells were stained and G418 resistant
colonies were enumerated. Colony numbers from repli-
cate plates were averaged and multiplied by 10 to give
the total colonies per infection.
T-cell interference studies
Fifty thousand LESN-3201, LCSN-3201, or LXSN-3201
cells were infected with 61E-DC/LAPSN or EECC-DC/
LAPSN at an m.o.i. of 2.0 in the presence of 4 mg
polybrene per milliliter. One day postinfection, the cells
were washed and resuspended in 1 ml fresh 3201 media.
At 2 days postinfection, the cells were stained to assay
either for levels of alkaline phosphatase expression or
FeLV Env-SU expression using flow cytometry as de-
scribed above.
Host range studies
Viruses carrying the LAPSN vector (61E-DC/LAPSN,
EECC-DC/LAPSN, and EEZZ/LAPSN) were used to ana-
lyze viral host range. For this purpose, a variety of ad-
herent cell lines were seeded at 1–2 3 104 cells per well
of a 24-well plate. The following day, the cells were
infected in the presence of 4 mg polybrene per milliliter.
At 2 days postinfection, the cells were stained for alka-
line phosphatase activity (Fields-Berry et al., 1992) and
the plates were scored by enumerating foci of two to four
cells that stained purple. In feline and other adherent cell
types, G418-resistant titers were determined as de-
scribed above for interference studies. The titers of 61E-
DC/LAPSN and EECC-DC/LAPSN were determined on
feline 3201 T-cells using both G418 resistance and alka-
line phosphatase expression to detect infection. Alkaline
phosphatase expression in infected 3201 cells was de-
termined by flow cytometry as described above. A titer
based on G418 resistance for 3201 cells infected with
EECC-DC/LAPSN and 61E-DC/LAPSN was determined
by end point dilution of viral supernatant and subsequent
selection of cells in G418 as described previously (Rohn
et al., submitted for publication).
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